Literature DB >> 33933174

Fertility preservation in men: a contemporary overview and a look toward emerging technologies.

Robert E Brannigan1, Richard J Fantus2, Joshua A Halpern2.   

Abstract

Cancer and oncologic therapies can have significant adverse effects on male reproductive potential, leaving many men permanently infertile. Fertility preservation has emerged as a key survivorship issue over the past 20 years, and numerous professional societies have published guidelines calling for fertility preservation to become a routine component of oncologic care. Most males with cancer are able to produce a semen specimen for fertility preservation, but numerous other methods of sperm procurement are available for patients who cannot provide a sufficient sample. Despite these options, fertility preservation will remain a challenge for prepubertal boys and men without sperm production. For these patients, experimental and investigational approaches offer the hope that one day they will translate to the clinical arena, offering additional pathways for successful fertility preservation care.
Copyright © 2021 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer; fertility preservation; infertility; oncofertility; sperm

Year:  2021        PMID: 33933174     DOI: 10.1016/j.fertnstert.2021.03.026

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  2 in total

1.  Effect of Malignancy on Semen Parameters.

Authors:  Guy Shrem; Liat Azani; Ido Feferkorn; Tamar Listovsky; Sofia Hussaini; Benjamin Farber; Michael H Dahan; Mali Salmon-Divon
Journal:  Life (Basel)       Date:  2022-06-20

Review 2.  Germline stem cells in human.

Authors:  Hanhua Cheng; Dantong Shang; Rongjia Zhou
Journal:  Signal Transduct Target Ther       Date:  2022-10-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.